These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31068410)

  • 21. [Factors limiting glycaemic control in insulin-treated type 2 diabetes].
    Ferencz V; Domján B; Gerő L; Tänczer T; Tabák GÁ
    Orv Hetil; 2015 Sep; 156(36):1443-50. PubMed ID: 26320598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycemic variability during algorithmic titration of insulin among hospitalized patients with type 2 diabetes and heart failure.
    Dungan K; Binkley P; Osei K
    J Diabetes Complications; 2016; 30(1):150-4. PubMed ID: 26475503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets.
    Migdal A; Abrahamson M; Peters A; Vint N
    Ann Med; 2018 Sep; 50(6):453-460. PubMed ID: 30103624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effectiveness and safety of different basal insulins in a real-world setting.
    Ji L; Zhang P; Zhu D; Lu J; Guo X; Wu Y; Li X; Ji J; Jia W; Yang W; Zou D; Zhou Z; Gao Y; Garg SK; Pan C; Weng J; Paul SK;
    Diabetes Obes Metab; 2017 Aug; 19(8):1116-1126. PubMed ID: 28230322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
    Garber AJ; Wahlen J; Wahl T; Bressler P; Braceras R; Allen E; Jain R
    Diabetes Obes Metab; 2006 Jan; 8(1):58-66. PubMed ID: 16367883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparable efficacy with similarly low risk of hypoglycaemia in patient- vs physician-managed basal insulin initiation and titration in insulin-naïve type 2 diabetic subjects: The Italian Titration Approach Study.
    Bonadonna RC; Giaccari A; Buzzetti R; Perseghin G; Cucinotta D; Avogaro A; Aimaretti G; Larosa M; Fanelli CG; Bolli GB
    Diabetes Metab Res Rev; 2020 Sep; 36(6):e3304. PubMed ID: 32118347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Type 2 diabetes: hypoglycemia risk, weight gain... Will there soon be a new alternative to insulin?].
    MMW Fortschr Med; 2006 Sep; 148(37):54. PubMed ID: 17036907
    [No Abstract]   [Full Text] [Related]  

  • 28. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.
    Hollander P; Cooper J; Bregnhøj J; Pedersen CB
    Clin Ther; 2008 Nov; 30(11):1976-87. PubMed ID: 19108786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter, open-label, nonrandomized, observational safety study in subjects using insulin aspart in basal-bolus regimen for the treatment of diabetes.
    Krzymień J; Kobli T; Nazar M
    Pol Arch Med Wewn; 2010 Nov; 120(11):444-50. PubMed ID: 21102380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial).
    Oyer DS; Shepherd MD; Coulter FC; Bhargava A; Brett J; Chu PL; Trippe BS;
    Am J Med; 2009 Nov; 122(11):1043-9. PubMed ID: 19854333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insulin therapy is a personalized approach to glycemic management in diabetes].
    Demidova TY; Titova VV
    Ter Arkh; 2020 Dec; 92(12):201-206. PubMed ID: 33720595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of weight-based insulin glargine dose titration regimen compared with glucose level- and current dose-based regimens in hospitalized patients with type 2 diabetes: a randomized, controlled study.
    Li X; Du T; Li W; Zhang T; Liu H; Xiong Y
    Clin Ther; 2014 Sep; 36(9):1269-75. PubMed ID: 25062651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials.
    Lankisch MR; Del Prato S; Dain MP; Mullins P; Owens DR
    Prim Care Diabetes; 2016 Feb; 10(1):51-9. PubMed ID: 26150328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin.
    Shaefer CF; Anderson J
    Postgrad Med; 2016 Jan; 128(1):137-44. PubMed ID: 26548422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe hypoglycemia rates and associated costs among type 2 diabetics starting basal insulin therapy in the United States.
    Ganz ML; Wintfeld NS; Li Q; Lee YC; Gatt E; Huang JC
    Curr Med Res Opin; 2014 Oct; 30(10):1991-2000. PubMed ID: 24945720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency and awareness of hypoglycemia in patients with Type 2 Diabetes treated with two or more insulin injections in primary care outpatient clinics.
    Cabré C; Colungo C; Vinagre I; Jansà M; Conget I
    Prim Care Diabetes; 2020 Apr; 14(2):168-172. PubMed ID: 31474469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and Safety of Physician-Led Versus Patient-Led Titration of Insulin Glargine in Indian Patients with Type 2 Diabetes Mellitus: A Subanalysis of the Asian Treat to Target Lantus Study (ATLAS).
    Misra A; Patel M; Agarwal P; Lodha S; Tandon N; Magdum M; Yajnik C; Ghosh R; Walekar A
    Diabetes Technol Ther; 2019 Nov; 21(11):656-664. PubMed ID: 31335198
    [No Abstract]   [Full Text] [Related]  

  • 38. Self-titration of insulin in the management of people with type 2 diabetes: a practical solution to improve management in primary care.
    Khunti K; Davies MJ; Kalra S
    Diabetes Obes Metab; 2013 Aug; 15(8):690-700. PubMed ID: 23253563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.
    Rosenstock J; Zinman B; Murphy LJ; Clement SC; Moore P; Bowering CK; Hendler R; Lan SP; Cefalu WT
    Ann Intern Med; 2005 Oct; 143(8):549-58. PubMed ID: 16230721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin therapy for challenging patient cases.
    Shubrook JH
    J Am Osteopath Assoc; 2013 Apr; 113(4 Suppl 2):S17-28. PubMed ID: 23545887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.